恢复衰老大脑与身体的年轻活力
摘要
斯坦福大学神经学教授、Knight脑韧性计划主任Tony Wyss-Coray博士，分享了他的突破性研究。该研究表明，年轻血液及运动后血液中的某些因子能够使衰老的大脑和其他器官恢复活力。他阐释了不同器官的衰老速率差异、血液蛋白如何预测未来疾病风险，以及哪些生活方式和分子层面的干预手段在延长健康寿命方面最具前景。对话涵盖了异体共生实验、器官特异性衰老时钟、禁食、运动生化机制，以及抗衰老医学的未来方向。
核心要点
- 年轻血液含有具有年轻化作用的蛋白质，能够重新激活干细胞、减少大脑Inflammation 炎症，并改善老年动物的记忆功能——其中部分效果已在人类研究中得到验证
- 同一个体体内，不同器官的衰老速率各不相同，血液蛋白质组合可以估算心脏、肝脏、肾脏和大脑等特定器官的”生物学年龄”
- “年龄差距”——实际年龄与器官估算生物学年龄之间的差值——是预测该器官未来患病风险的重要指标
- 运动可促使肝脏向血液中释放有益蛋白质（包括clusterin），这些蛋白质随血液循环到达大脑，从而改善认知功能
- 人类血液蛋白质组成存在三个主要”衰老浪潮”：分别发生在35岁前后、40岁初期和60岁初期——这些是生物学变化加速的阶段
- 热量限制与禁食在动物实验中能激活广泛有益的生理通路（减少Inflammation 炎症、改善蛋白质更新、减轻氧化损伤），但目前尚无临床试验明确证实其可延长人类寿命
- **将年轻动物的脑脊液（CSF）**输注到老年动物体内，可使大脑再生并改善认知功能，尤其对少突胶质细胞具有针对性作用
- **不存在单一的”神奇分子”**能够逆转衰老——年轻血液含有许多针对不同细胞类型和通路的因子，这表明多因子或器官靶向方法将是必然选择
- 器官特异性生物年龄检测现已通过Vero Biosciences等公司实现商业化，可实现个性化干预与长期监测
详细笔记
异体共生：年轻血液实验
Parabiosis是一种手术实验模型，将老年小鼠与年轻小鼠配对，使两者的循环系统互通血液。该模型最初由斯坦福大学Tom Rando博士用于研究肌肉干细胞衰老，后由Wyss-Coray实验室将其拓展至大脑研究领域。
小鼠实验的关键发现：
- 将年轻血液输注到老年动物体内，可重新激活大脑干细胞
- 减少神经炎症
- 增强神经元可测量的电活动
- 改善记忆功能
后续实验测试了人类年轻血液是否对小鼠大脑具有类似效果——结果证实确有此效，表明这一机制在物种间具有保守性。
向人类的转化：
- 针对阿尔茨海默症和帕金森症患者使用血浆组分（来源于Grifols公司汇集的捐献者血浆）的临床试验显示出令人振奋的早期结果
- 一项纳入500名患者的双盲安慰剂对照试验，采用治疗性血浆置换联合白蛋白输注的方案，在阿尔茨海默症患者中显示出显著的认知获益
- Circulate Therapeutics针对健康老年人开展的一项规模较小的40人安慰剂对照研究，显示部分器官的epigenetic clock年龄出现可测量的下降
你无需储存自己的血液——汇集的年轻捐献者血液同样保留了研究中观察到的有益效果。
器官特异性衰老时钟
同一个体体内，不同器官的衰老速率各不相同。Wyss-Coray团队通过测量大规模人群队列中数千种血液蛋白质（目前的平台最多可检测11,000种），并对其进行数十年追踪，发现了这一规律。
工作原理：
- 血液中的蛋白质来源于特定器官（大脑、肝脏、心脏、肾脏等）
- 这些蛋白质浓度随年龄变化的轨迹，可估算出该器官的生物学年龄
- “年龄差距”（器官生物学年龄减去实际年龄）可预测该器官未来的患病风险
预测价值：
- 心脏衰老加速 → 心脏病/心肌梗死风险升高
- 大脑衰老加速 → 阿尔茨海默症风险升高
- 肾脏衰老加速 → 肾脏疾病风险升高
商业化应用： Wyss-Coray联合创立了Vero Biosciences，推出”Vero Compass”平台——该平台整合生物学年龄特征与临床数据及可穿戴设备数据，用于识别高风险器官、推荐干预措施并追踪干预效果。
血液中的衰老浪潮
对人类全生命周期（20至90岁）血液蛋白质组成的分析揭示了非线性衰老规律，存在明显的拐点：
- 约35岁： 第一波主要浪潮——男性和女性的蛋白质浓度均发生剧烈变化
- 约40岁初期： 第二波生物学变化加速
- 约60岁初期： 第三波
这些浪潮可能反映了进化编程的结果：一旦完成生殖任务（约30至40岁），维持有机体的进化压力便大幅降低。这一概念在衰老生物学中被称为antagonistic pleiotropy（拮抗多效性）——在年轻时有益的因素，在年老后可能转变为有害因素。
运动来源的血液因子
运动对大脑的有益影响，不仅仅来自直接的神经学刺激，还通过释放入循环系统的血源性因子实现。
关键发现：
- 将经过运动训练的年轻小鼠血液输注到未经运动的老年小鼠体内，产生的大脑获益强于未经运动的年轻血液
- 运动似乎能促使肝脏释放因子，这些因子随后传递至大脑
已鉴定的特定分子：
- Clusterin（载脂蛋白J）： 运动后由肝脏释放；参与脂质结合、补体通路和突触重塑。向小鼠注射合成clusterin，可模拟运动对大脑的部分有益作用
- GPLD1（GPI特异性磷脂酶D1）： 由Saul Villeda博士鉴定；在运动后血液中被证实对大脑具有有益作用
- 运动后血液在动物间转移时，还能模拟热量限制的部分效果
禁食与热量限制
Intermittent fasting目前尚无公认的临床定义，也没有大规模人类临床试验明确证明其能延长寿命。然而，动物研究始终表明：
- 减少炎症
- 改善蛋白质更新及细胞”废物”清除
- 减轻氧化损伤
- 改善细胞层面的能量代谢
Wyss-Coray博士的个人实践：
- 曾多次尝试Walter Longo的模拟禁食饮食：连续5天每日约摄入1,000卡路里，主要以脂肪为主（ketogenic diet方案）
- 通常不严格执行intermittent fasting
- 注意到禁食期间主观上有警觉性提升——归因于儿茶酚胺（Dopamine 多巴胺/肾上腺素）水平升高
注意事项： 部分灵长类动物研究表明，禁食在某些情况下可能产生不利影响（例如，某些猴子禁食研究中出现肾功能下降）。动物研究向人类研究的转化仍存在不确定性。
脑脊液（CSF）与大脑再生
将年轻动物的脑脊液通过泵持续输注到老年小鼠体内，为期一个月：
- 改善认知功能
- 主要细胞靶点： Oligodendrocytes（少突胶质细胞）——负责产生髓鞘（神经连接的”绝缘层”）的细胞
- 脑脊液的成分随年龄增长发生显著变化
人类脑脊液中突触蛋白的比例，是预测认知韧性或衰退的有力指标——而这些比例从成年早期便开始发生变化。
前景看好的抗衰老分子（研究阶段）
| 分子 | 来源 | 拟议效果 |
|---|---|---|
| Clusterin | 肝脏（运动诱导） | 大脑功能、脂质结合、突触重塑 |
| GDF11（生长分化因子11） | 年轻血液 | 多器官年轻化（存在争议） |
| GPLD1 | 运动后血液 | 通过肝脑轴发挥大脑获益 |
| Klotho | 多种来源 | 对多个器官具有有益作用；抑制衰老蛋白 |
| IGF-1 | 年轻血液 | 生长与组织维护（但高水平也与寿命缩短相关） |
重要提示： 上述分子均未获批用于抗衰老用途。自行使用未经监管的
English Original 英文原文
Restoring Youthfulness & Vitality to the Aging Brain & Body
Summary
Dr. Tony Wyss-Coray, professor of neurology at Stanford and director of the Knight Initiative for Brain Resilience, discusses his groundbreaking research showing that factors in young blood and exercise-conditioned blood can rejuvenate the aging brain and other organs. He explains how different organs age at different rates, how blood proteins can predict future disease risk, and what lifestyle and molecular approaches show the most promise for extending healthspan. The conversation spans parabiosis experiments, organ-specific aging clocks, fasting, exercise biochemistry, and the future of rejuvenation medicine.
Key Takeaways
- Young blood contains rejuvenating proteins that can reactivate stem cells, reduce brain Inflammation 炎症, and improve memory in aged animals — and some of these effects translate to humans
- Organs age at different rates within the same individual, and a blood protein panel can estimate the “biological age” of specific organs like the heart, liver, kidney, and brain
- An “age gap” — the difference between your actual age and your organ’s estimated biological age — is a strong predictor of future disease risk in that organ
- Exercise triggers the liver to release beneficial proteins (including clusterin) into the bloodstream that travel to the brain and improve cognitive function
- There are three major “waves of aging” in human blood protein composition: around age 35, early 40s, and early 60s — these are accelerated phases of biological change
- Caloric restriction and fasting activate broadly beneficial pathways in animals (reduced Inflammation 炎症, improved protein turnover, less oxidative damage), but no clinical trials have clearly demonstrated lifespan extension in humans
- Cerebrospinal fluid (CSF) from young animals infused into old animals regenerates the brain and improves cognitive function, particularly targeting oligodendrocytes
- No single “miracle molecule” is likely to reverse aging — young blood contains many factors targeting different cell types and pathways, suggesting multi-factor or organ-targeted approaches will be necessary
- Organ-specific biological age testing is now commercially available through companies like Vero Biosciences, enabling personalized intervention and monitoring
Detailed Notes
Parabiosis: The Young Blood Experiments
Parabiosis is a surgical model in which an old and a young mouse are paired so their circulatory systems exchange blood. Originally pioneered for studying muscle stem cell aging by Dr. Tom Rando at Stanford, the model was extended to the brain by Wyss-Coray’s lab.
Key findings in mice:
- Infusing young blood into old animals reactivated brain stem cells
- Reduced neuroinflammation
- Increased measurable electrical activity in neurons
- Improved memory function
Experiments then tested whether human young blood had similar effects on mouse brains — it did, suggesting conserved mechanisms across species.
Translation to humans:
- Clinical trials in Alzheimer’s and Parkinson’s patients using plasma fractions (sourced from pooled donor plasma via company Grifols) showed promising early results
- A 500-patient blinded, placebo-controlled trial using therapeutic plasma exchange combined with albumin infusion showed significant cognitive benefits in Alzheimer’s patients
- A smaller 40-person placebo-controlled study by Circulate Therapeutics in healthy older adults showed measurable decreases in epigenetic clock age of some organs
You do not need to bank your own blood — pooled young donor blood retains the beneficial effects seen in studies.
Organ-Specific Aging Clocks
Different organs age at different rates within the same person. Wyss-Coray’s team identified this by measuring thousands of blood proteins (up to 11,000 with current platforms) in large population cohorts tracked over decades.
How it works:
- Proteins in blood originate from specific organs (brain, liver, heart, kidney, etc.)
- The concentration trajectory of these proteins across age estimates the biological age of that organ
- An “age gap” (biological organ age minus chronological age) predicts future disease risk in that organ
Predictive value:
- Heart aging faster → higher risk of heart disease/heart attack
- Brain aging faster → higher risk of Alzheimer’s disease
- Kidney aging faster → higher risk of kidney disease
Commercial availability: Wyss-Coray co-founded Vero Biosciences, which offers the “Vero Compass” — a platform combining biological age signatures with clinical and wearable data to identify at-risk organs, recommend interventions, and track response over time.
Waves of Aging in the Blood
Analysis of blood protein composition across the human lifespan (ages 20–90) revealed non-linear aging with distinct inflection points:
- ~Age 35: First major wave — dramatic changes in protein concentrations in both men and women
- ~Early 40s: Second wave of accelerated biological change
- ~Early 60s: Third wave
These waves may reflect evolutionary programming: once reproductive duties are fulfilled (~30–40 years), there is little evolutionary pressure to maintain the organism. This concept is known in aging biology as antagonistic pleiotropy — factors beneficial in youth can become harmful in old age.
Exercise-Derived Blood Factors
Exercise produces beneficial effects on the brain not just through direct neurological stimulation but via bloodborne factors released into circulation.
Key findings:
- Exercised young mouse blood infused into non-exercised old mice produced stronger brain benefits than non-exercised young blood
- Exercise appears to trigger the liver to release factors that travel to the brain
Specific molecules identified:
- Clusterin (Apolipoprotein J): Released from the liver after exercise; involved in lipid binding, complement pathways, and synapse remodeling. Synthetic clusterin injected into mice mimicked some exercise benefits on the brain
- GPLD1 (GPI-specific phospholipase D1): Identified by Dr. Saul Villeda; shown to have brain-beneficial effects in exercise-conditioned blood
- Exercise-conditioned blood also mimics some effects of caloric restriction when transferred between animals
Fasting and Caloric Restriction
Intermittent fasting has no agreed-upon clinical definition and no large human clinical trials demonstrating clear lifespan extension. However, animal studies consistently show:
- Reduced inflammation
- Improved protein turnover and clearance of cellular “garbage”
- Reduced oxidative damage
- Improved energy metabolism at the cellular level
Dr. Wyss-Coray’s personal practice:
- Has tried Walter Longo’s fasting-mimicking diet several times: ~1,000 calories/day for 5 days, primarily fat-based (ketogenic diet approach)
- Generally does not practice strict intermittent fasting
- Notes a subjective increase in alertness during fasting — attributed to catecholamine (Dopamine 多巴胺/epinephrine) increases
Caution: Some primate studies suggest fasting may be detrimental in certain contexts (e.g., worse kidney function in some monkey fasting studies). Translation from animal to human studies remains uncertain.
Cerebrospinal Fluid (CSF) and Brain Rejuvenation
Young CSF infused continuously into old mice via pump over one month:
- Improved cognitive function
- Primary cellular target: Oligodendrocytes — the cells that produce myelin (the “insulation” around neuronal connections)
- CSF composition changes dramatically with age
Synaptic protein ratios in human CSF are strong predictors of cognitive resilience or decline — and these ratios begin shifting from early adulthood onward.
Promising Rejuvenation Molecules (In Research)
| Molecule | Source | Proposed Effect |
|---|---|---|
| Clusterin | Liver (exercise-induced) | Brain function, lipid binding, synaptic remodeling |
| GDF11 (Growth Differentiation Factor 11) | Young blood | Multi-organ rejuvenation (contested) |
| GPLD1 | Exercise-conditioned blood | Brain benefits via liver-brain axis |
| Klotho | Multiple | Beneficial effects on multiple organs; aging-suppressor protein |
| IGF-1 | Young blood | Growth and tissue maintenance (but also associated with shorter lifespan at high levels) |
Important: None of these have been approved for anti-aging use. Self-administering unreg